Back to BCRX
Creative Planning BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
8
Latest value
$601K
Q3 2026
Peak value
$769K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $595K |
| Q3 2025 | $76K |
| Q4 2025 | $388K |
| Q1 2026 | $587K |
| Q2 2026 | $68K |
| Q2 2026 | $769K |
| Q3 2026 | $60K |
| Q3 2026 | $601K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $601K | 72.1K | — | — |
| Q3 2026 | $60K | 7.2K | — | — |
| Q2 2026 | $769K | 76.9K | — | — |
| Q2 2026 | $68K | 6.8K | — | — |
| Q1 2026 | $587K | 61.7K | — | — |
| Q4 2025 | $388K | 49.8K | — | — |
| Q3 2025 | $76K | 10.0K | — | — |
| Q3 2025 | $595K | 78.4K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M